Search / Trial NCT06231264

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Launched by XIJING HOSPITAL · Jan 19, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥18 years
  • 2. Ulcerative colitis diagnosed for at least 3 mouths.
  • 3. Mayo score 4-10, Mayo endoscopic score 2-3 points
  • 4. Resistant to at least one type of medical treatments
  • Exclusion Criteria:
  • 1. Treatment-naive ulcerative colitis (no previous treatment)
  • 2. Acute severe ulcerative colitis
  • 3. Previous surgical treatment or severe colitis at imminent risk of surgery infective colitis
  • 4. Other systemic diseases
  • 5. Pregnancy and lactation
  • 6. Allergic to the electrode patch

About Xijing Hospital

Xijing Hospital, a prominent medical institution affiliated with the Fourth Military Medical University in Xi'an, China, is dedicated to advancing healthcare through innovative clinical research. Renowned for its comprehensive range of medical services and expertise in various specialties, Xijing Hospital actively sponsors clinical trials aimed at evaluating new therapies, improving patient outcomes, and contributing to scientific knowledge. With a commitment to ethical standards and patient safety, the hospital fosters collaboration among multidisciplinary teams to drive forward the development of effective treatment options that address critical health challenges.

Locations

Xi'an, Shaanxi, China

Xi'an, Shaanxi, China

Xi'an, Shaanxi, China

Xi'an, Shaanxi, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0